Practical considerations in medical cannabis administration and dosing
Top Cited Papers
- 4 January 2018
- journal article
- review article
- Published by Elsevier BV in European Journal of Internal Medicine
- Vol. 49, 12-19
- https://doi.org/10.1016/j.ejim.2018.01.004
Abstract
No abstract availableKeywords
This publication has 70 references indexed in Scilit:
- Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophreniaTranslational Psychiatry, 2012
- Prospects for cannabinoid therapies in basal ganglia disordersBritish Journal of Pharmacology, 2011
- Taming THC: potential cannabis synergy and phytocannabinoid‐terpenoid entourage effectsBritish Journal of Pharmacology, 2011
- Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia PatientsNeuropsychopharmacology, 2011
- Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibitionMolecular Cancer, 2010
- Cannabis as a substitute for alcohol and other drugsHarm Reduction Journal, 2009
- Human Cannabinoid PharmacokineticsChemistry & Biodiversity, 2007
- Decreased respiratory symptoms in cannabis users who vaporizeHarm Reduction Journal, 2007
- The Endocannabinoid System as an Emerging Target of PharmacotherapyPharmacological Reviews, 2006
- A pilot clinical study of Δ9-tetrahydrocannabinol in patients with recurrent glioblastoma multiformeBritish Journal of Cancer, 2006